Ruxolitinib in Combination with Nilotinib and Prednisolone, a New Synergistic Approach to Treat Myelofibrosis
Alicia Arenas(Universidad de Sevilla), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Pilar Hernández-Campo, Rosa Ayala(Hospital Universitario 12 De Octubre), Julián Gorrochategui, Daniel Primo, Joan Ballesteros, Blanca Ferrer Lores(Hospital Clínico Universitario de Valencia)
Cited by 1
Related Papers
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523